On Friday, February 6, the Dow Jones Industrial Average led a market rebound by surging about 2.5%, climbing to more than 50,000 points for the first time.  Investors cited easing inflation data, a resilient economy and optimism around artificial intelligence investments as key drivers, though analysts cautioned about potential volatility ahead of upcoming Federal Reserve comments.

In a seismic shift for American healthcare, President Donald Trump's revived Most Favored Nations (MFN) policy is slashing prescription drug prices by tying them to the lowest rates in other developed countries, promising billions in savings for patients and taxpayers. But as the administration secures landmark deals with major pharmaceutical giants, critics point to a history of Democratic resistance.